These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1384 related articles for article (PubMed ID: 9346226)
21. Paclitaxel in lung cancer: 1-hour infusions given alone or in combination chemotherapy. Hainsworth JD; Greco FA Semin Oncol; 1995 Dec; 22(6 Suppl 15):45-9. PubMed ID: 8643970 [TBL] [Abstract][Full Text] [Related]
22. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer. Klaassen U; Harstrick A; Wilke H; Seeber S Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037 [TBL] [Abstract][Full Text] [Related]
23. Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial. Meerpohl HG; du Bois A; Luck HJ; Kühnle H; Möbus V; Kreienberg R; Bauknecht T; Köchli O; Bochtler H; Diergarten K Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-17-S2-22. PubMed ID: 9045330 [TBL] [Abstract][Full Text] [Related]
24. The activity of paclitaxel in gastrointestinal tumors. Ajani JA; Ilson DH; Kelsen DP Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861 [TBL] [Abstract][Full Text] [Related]
25. Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma. Holmes FA Semin Oncol; 1995 Aug; 22(4 Suppl 8):9-15. PubMed ID: 7543702 [TBL] [Abstract][Full Text] [Related]
27. Phase II trial of weekly paclitaxel, cisplatin plus infusional high dose 5-fluorouracil and leucovorin for metastatic urothelial carcinoma. Lin CC; Hsu CH; Huang CY; Cheng AL; Vogelzang NJ; Pu YS J Urol; 2007 Jan; 177(1):84-9; discussion 89. PubMed ID: 17162009 [TBL] [Abstract][Full Text] [Related]
28. Preliminary results of a phase I/II clinical trial of paclitaxel and carboplatin in non-small cell lung cancer. Natale RB Semin Oncol; 1996 Oct; 23(5 Suppl 12):2-6. PubMed ID: 8941402 [TBL] [Abstract][Full Text] [Related]
29. Paclitaxel and 5-fluorouracil in metastatic breast cancer: the US experience. Paul DM; Garrett AM; Meshad M; DeVore RD; Porter LL; Johnson DH Semin Oncol; 1996 Feb; 23(1 Suppl 1):48-52. PubMed ID: 8629038 [TBL] [Abstract][Full Text] [Related]
36. Activity and safety of epirubicin plus paclitaxel in advanced breast cancer. Conte PF; Michelotti A; Baldini E; Tibaldi C; DaPrato M; Salvadori B; Giannessi PG; Gentile A; Biadi O; Mariani M Semin Oncol; 1996 Feb; 23(1 Suppl 1):28-32. PubMed ID: 8629033 [TBL] [Abstract][Full Text] [Related]
37. Pilot study with fixed-dose carboplatin and escalating paclitaxel in advanced ovarian cancer. Bolis G Semin Oncol; 1995 Dec; 22(6 Suppl 14):32-4. PubMed ID: 8553081 [TBL] [Abstract][Full Text] [Related]
38. Carboplatin plus paclitaxel in the first-line treatment of advanced ovarian cancer: preliminary results of a phase I study. Lhommé C; Kerbrat P; Lejeune C; Guastalla JP; Fumoleau P; Goupil A; Héron JF; Cassin MA; Pruvot I; Soares JA; Chazard M Semin Oncol; 1996 Oct; 23(5 Suppl 12):48-54. PubMed ID: 8941410 [TBL] [Abstract][Full Text] [Related]
39. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC). Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237 [TBL] [Abstract][Full Text] [Related]
40. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes. Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]